Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a global
prevalence estimated at approximately 25%. NAFLD is also the leading cause of liver …

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver
disease affecting approximately 25% of the global population. Although a majority of NAFLD …

Because of the global obesity epidemic, the incidence and prevalence of nonalcoholic fatty
liver disease (NAFLD) have increased worldwide, including among Koreans. Recently, the …

The incidence of nonalcoholic fatty liver disease (NAFLD) is continuing to rise worldwide,
and it is estimated that this disquieting trend will continue for another 10–15 years before …

Background Nonalcoholic fatty liver disease (NAFLD) is a common diagnosis in clinical
practice. Insulin resistance and oxidative stress play an important role in NAFLD …

Nonalcoholic fatty liver disease (NAFLD) is a systemic disorder with a complex multifactorial
pathogenesis and heterogenous clinical manifestations. NAFLD, once believed to be an …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease.
NAFLD includes a wide spectrum of liver conditions ranging from simple steatosis to …

Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic fat
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …

Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of metabolic states ranging
from simple steatosis to inflammation with associated fibrosis to cirrhosis. Though …

The growing burden of non-alcoholic fatty liver disease (NAFLD) parallels the increasing
prevalence of obesity in Asia. The overall prevalence of NAFLD in Asia is now estimated to …